Home/IAMA Therapeutics/Torsten M. Madsen
TM

Torsten M. Madsen

Chief Executive Officer

IAMA Therapeutics

IAMA Therapeutics Pipeline

DrugIndicationPhase
NKCC1 Inhibitor ProgramAutism, Epilepsies, and other CNS disordersPhase 1